XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.86

+0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: charles moore who wrote (7092)	8/31/1998 7:57:00 PM
From: Dan O	Read Replies (1) of 17367

Ellen Martin, I know you check out the boards. What can you say about these concerns? Certainly, a buyout at a small premium to todays market would be an insult to most shareholders since most have probably bought in at double or triple today's level. Further, a buyout at low prices during a temporary slump in biotech stocks right before anticipated FDA action would surely result in well rewarded shareholder suits. Can the company provide the shareholders with comfort in this regard so we can put this aside? Perhaps you can share the intended use of the study and its preliminary results? I believe you have posted here before. It would be helpful to do so again. Dan O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next